ENTRESTO PATENTS FACING OPPOSITIONS
ENTRESTO facing oppositions at the European Patent Office (EPO)
| Patent Number | Title | Applicants | Legal Status | Legal Status Date | Oppositions | Activity Alert |
|---|---|---|---|---|---|---|
| EP1948158B1 | Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor | Revoked | May 26, 2023 |
MAIWALD PATENTANWALTS
| ||
| EP3294283B1 | Sacubitril-valsartan dosage regimen for treating heart failure | Granted and Under Opposition | Feb 03, 2023 |
EGIS
CAMULON
DR. SCHON, NEYMEYR & PARTNER
HOFFMANN EITLE
SANOVEL IIAC
SYNTHON BV
BETAPHARM ARZNEIMITTEL
ZAKLADY FARMACEUTYCZNE POLPHARMA
ALFRED E. TIEFENBACHER
TEVA PHARMACEUTICAL
GENERICS
STRAWMAN
BULLE DR., JAN
KRKA, NOVO MESTO
ZENTIVA, K.S.
| ||
| EP2887961B1 | Nep inhibitors for treating diseases characterized by atrial enlargement or remodeling | Revoked | Dec 09, 2022 |
ALFRED E. TIEFENBACHER
TEVA PHARMACEUTICAL
WUESTHOFF & WUESTHOFF
STADA ARZNEIMITTEL
GENERICS
ALGEMEEN OCTROOI- EN MERKENBUREAU B.V.
| ||
| EP2340828B1 | Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor | Granted and Under Opposition | Jun 12, 2020 |
GENERICS
SANOVEL ILAC
D YOUNG & CO
STADA ARZNEIMITTEL
KRKA, NOVO MESTO
BETAPHARM ARZNEIMITTEL
ZAKLADY FARMACEUTYCZNE POLPHARMA
ALFRED E. TIEFENBACHER
| ||
| EP1467728B1 | Pharmaceutical compositions comprising valsartan and nep inhibitors | Opposition procedure closed | Sep 24, 2010 |
MUNDIPHARMA
|